5398712025-07-012025-09-305398712025-09-305398712025-03-315398712025-04-012025-09-305398712025-07-012025-09-30in-capmkt:OtherExpenses1Member5398712025-04-012025-09-30in-capmkt:OtherExpenses1Member5398712025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15398712025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15398712025-07-012025-09-30RelatedPartyTransactionDomain15398712025-06-30RelatedPartyTransactionDomain15398712025-09-30RelatedPartyTransactionDomain15398712025-07-012025-09-30RelatedPartyTransactionDomain25398712025-06-30RelatedPartyTransactionDomain25398712025-09-30RelatedPartyTransactionDomain25398712025-07-012025-09-30RelatedPartyTransactionDomain35398712025-06-30RelatedPartyTransactionDomain35398712025-09-30RelatedPartyTransactionDomain35398712025-07-012025-09-30RelatedPartyTransactionDomain45398712025-06-30RelatedPartyTransactionDomain45398712025-09-30RelatedPartyTransactionDomain45398712025-07-012025-09-30RelatedPartyTransactionDomain55398712025-06-30RelatedPartyTransactionDomain55398712025-09-30RelatedPartyTransactionDomain55398712025-07-012025-09-30RelatedPartyTransactionDomain65398712025-06-30RelatedPartyTransactionDomain65398712025-09-30RelatedPartyTransactionDomain65398712025-07-012025-09-30RelatedPartyTransactionDomain75398712025-06-30RelatedPartyTransactionDomain75398712025-09-30RelatedPartyTransactionDomain75398712025-07-012025-09-30RelatedPartyTransactionDomain85398712025-06-30RelatedPartyTransactionDomain85398712025-09-30RelatedPartyTransactionDomain85398712025-07-012025-09-30RelatedPartyTransactionDomain95398712025-06-30RelatedPartyTransactionDomain95398712025-09-30RelatedPartyTransactionDomain95398712025-07-012025-09-30RelatedPartyTransactionDomain105398712025-06-30RelatedPartyTransactionDomain105398712025-09-30RelatedPartyTransactionDomain105398712025-07-012025-09-30RelatedPartyTransactionDomain115398712025-06-30RelatedPartyTransactionDomain115398712025-09-30RelatedPartyTransactionDomain115398712025-07-012025-09-30RelatedPartyTransactionDomain125398712025-06-30RelatedPartyTransactionDomain125398712025-09-30RelatedPartyTransactionDomain125398712025-07-012025-09-30RelatedPartyTransactionDomain135398712025-06-30RelatedPartyTransactionDomain135398712025-09-30RelatedPartyTransactionDomain135398712025-07-012025-09-30RelatedPartyTransactionDomain145398712025-06-30RelatedPartyTransactionDomain145398712025-09-30RelatedPartyTransactionDomain145398712025-07-012025-09-30RelatedPartyTransactionDomain155398712025-06-30RelatedPartyTransactionDomain155398712025-09-30RelatedPartyTransactionDomain155398712025-07-012025-09-30RelatedPartyTransactionDomain165398712025-06-30RelatedPartyTransactionDomain165398712025-09-30RelatedPartyTransactionDomain165398712025-07-012025-09-30RelatedPartyTransactionDomain175398712025-06-30RelatedPartyTransactionDomain175398712025-09-30RelatedPartyTransactionDomain175398712025-07-012025-09-30RelatedPartyTransactionDomain185398712025-06-30RelatedPartyTransactionDomain185398712025-09-30RelatedPartyTransactionDomain185398712025-07-012025-09-30RelatedPartyTransactionDomain195398712025-06-30RelatedPartyTransactionDomain195398712025-09-30RelatedPartyTransactionDomain195398712025-07-012025-09-30RelatedPartyTransactionDomain205398712025-06-30RelatedPartyTransactionDomain205398712025-09-30RelatedPartyTransactionDomain205398712025-07-012025-09-30RelatedPartyTransactionDomain215398712025-06-30RelatedPartyTransactionDomain215398712025-09-30RelatedPartyTransactionDomain215398712025-07-012025-09-30RelatedPartyTransactionDomain225398712025-06-30RelatedPartyTransactionDomain225398712025-09-30RelatedPartyTransactionDomain225398712025-07-012025-09-30RelatedPartyTransactionDomain235398712025-06-30RelatedPartyTransactionDomain235398712025-09-30RelatedPartyTransactionDomain235398712025-07-012025-09-30RelatedPartyTransactionDomain245398712025-06-30RelatedPartyTransactionDomain245398712025-09-30RelatedPartyTransactionDomain245398712025-07-012025-09-30RelatedPartyTransactionDomain255398712025-06-30RelatedPartyTransactionDomain255398712025-09-30RelatedPartyTransactionDomain255398712025-07-012025-09-30RelatedPartyTransactionDomain265398712025-06-30RelatedPartyTransactionDomain265398712025-09-30RelatedPartyTransactionDomain265398712025-07-012025-09-30RelatedPartyTransactionDomain275398712025-06-30RelatedPartyTransactionDomain275398712025-09-30RelatedPartyTransactionDomain275398712025-07-012025-09-30RelatedPartyTransactionDomain285398712025-06-30RelatedPartyTransactionDomain285398712025-09-30RelatedPartyTransactionDomain285398712025-07-012025-09-30RelatedPartyTransactionDomain295398712025-06-30RelatedPartyTransactionDomain295398712025-09-30RelatedPartyTransactionDomain29iso4217:INRxbrli:pure iso4217:INRxbrli:shares

Integrated Filing (Finance) Ind AS


Thyrocare Technologies Limited


General Information

Scrip code*539871
NSE Symbol*THYROCARE
MSEI Symbol*NOTLISTED
ISIN*INE594H01019
Type of companyMain Board
Class of securityEquity
Date of start of financial year01-04-2025
Date of end of financial year31-03-2026
Date of board meeting when results were approved14-10-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange06-10-2025
Description of presentation currencyINR
Level of roundingCrores
Reporting TypeQuarterly
Reporting QuarterSecond quarter
Nature of report standalone or consolidatedStandalone
Whether results are audited or unaudited for the quarter endedUnaudited
Whether results are audited or unaudited for the Year to date for current period ended/year endedUnaudited
Segment ReportingSingle segment
Description of single segmentDiagnostic Testing Services
Start date of board meeting14-10-2025
Start time of board meeting15:00:00
End date of board meeting14-10-2025
End time of board meeting16:10:00
Whether cash flow statement is applicable on companytrue
Type of cash flow statementCash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualificationNot applicable
Whether the company has any related party?true
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?true
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/publicNA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of bank's staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.NA
(III) Whether the company is a 'high value debt listed entity' according to regulation 15 (1A)?false
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?true
Latest Date on which RPT policy is updated23-07-2025
Indicate Company website link for updated RPT policy of the Companyhttps://investor.thyrocare.com/policies-codes
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?false
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?falseTextual Information(1)

Text Block

Textual Information(1)There were no defaults on Loans and Debt Securities of the Company

Financial Results - Ind-AS

Amount in (Crores)

Particulars3 months/ 6 months ended (dd-mm-yyyy)Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period01-07-202501-04-2025
Date of end of reporting period30-09-202530-09-2025
Whether results are audited or unauditedUnauditedUnaudited
Nature of report standalone or consolidatedStandaloneStandalone
Part IBlue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1Income
Revenue from operations202.23381.12
Other income2.286.24
Total income204.51387.36
2Expenses
(a)Cost of materials consumed57.12109.49
(b)Purchases of stock-in-trade0.210.28
(c)Changes in inventories of finished goods, work-in-progress and stock-in-trade0.040.19
(d)Employee benefit expense31.3762.07
(e)Finance costs0.601.22
(f)Depreciation, depletion and amortisation expense9.7018.65
(g)Other Expenses
1Other expenses44.5883.66
Total other expenses44.5883.66
Total expenses143.62275.56
3Total profit before exceptional items and tax60.89111.80
4Exceptional items0.000.00
5Total profit before tax60.89111.80
6Tax expense
7Current tax16.9931.29
8Deferred tax0.871.43
9Total tax expenses17.8632.72
10Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement0.000.00
11Net Profit Loss for the period from continuing operations43.0379.08
12Profit (loss) from discontinued operations before tax0.000.00
13Tax expense of discontinued operations0.000.00
14Net profit (loss) from discontinued operation after tax0.000.00
15Share of profit (loss) of associates and joint ventures accounted for using equity method0.000.00
16Total profit (loss) for period43.0379.08
17Other comprehensive income net of taxes0.07(0.14)
18Total Comprehensive Income for the period43.1078.94
19Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21Details of equity share capital
Paid-up equity share capital52.9952.99
Face value of equity share capital10.0010.00
22Reserves excluding revaluation reserve
23Earnings per share
iEarnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations8.1214.92
Diluted earnings (loss) per share from continuing operations8.1114.89
iiEarnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations0.000.00
Diluted earnings (loss) per share from discontinued operations0.000.00
iiiEarnings per equity share (for continuing and discontinued operations)
Basic earnings (loss) per share from continuing and discontinued operations8.1214.92
Diluted earnings (loss) per share from continuing and discontinued operations8.1114.89
24Debt equity ratio0.000.00
25Debt service coverage ratio0.000.00
26Interest service coverage ratio0.000.00
27Remarks for debt equity ratio
28Remarks for debt service coverage ratio
29Remarks for interest service coverage ratio
30Disclosure of notes on financial resultsTextual Information(1)

Text Block

Textual Information(1)As per Signed PDF

Other Comprehensive Income

Amount in (Crores)

Particulars3 months/ 6 months ended (dd-mm-yyyy)Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period01-07-202501-04-2025
Date of end of reporting period30-09-202530-09-2025
Whether results are audited or unauditedUnauditedUnaudited
Nature of report standalone or consolidatedStandaloneStandalone
Other comprehensive income [Abstract]
1Amount of items that will not be reclassified to profit and loss
1Re-measurement of defined benefit (liability)/asset0.09(0.19)
Total Amount of items that will not be reclassified to profit and loss0.09(0.19)
2Income tax relating to items that will not be reclassified to profit or loss0.02(0.05)
3Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4Income tax relating to items that will be reclassified to profit or loss
5Total Other comprehensive income0.07(0.14)

Statement of Asset and Liabilities

Amount in (Crores)

ParticularsHalf Year ended (dd-mm-yyyy)
Date of start of reporting period01-04-2025
Date of end of reporting period30-09-2025
Whether results are audited or unauditedUnaudited
Nature of report standalone or consolidatedStandalone
Assets
1Non-current assets
Property, plant and equipment118.58
Capital work-in-progress3.05
Investment property0.94
Goodwill4.18
Other intangible assets36.58
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments180.97
Trade receivables, non-current
Loans, non-current0.00
Other non-current financial assets12.63
Total non-current financial assets193.60
Deferred tax assets (net)15.70
Other non-current assets1.38
Total non-current assets374.01
2Current assets
Inventories36.65
Current financial asset
Current investments83.68
Trade receivables, current70.12
Cash and cash equivalents29.05
Bank balance other than cash and cash equivalents39.26
Loans, current0.00
Other current financial assets18.67
Total current financial assets240.78
Current tax assets (net)
Other current assets
Total current assets277.43
3Non-current assets classified as held for sale
4Regulatory deferral account debit balances and related deferred tax Assets
Total assets651.44
Equity and liabilities
1Equity
Equity attributable to owners of parent
Equity share capital52.99
Other equity463.45
Total equity attributable to owners of parent516.44
Non controlling interest
Total equity516.44
2Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities20.09
Total non-current financial liabilities20.09
Provisions, non-current0.00
Deferred tax liabilities (net)
Deferred government grants, Non-current
Other non-current liabilities6.82
Total non-current liabilities26.91
Current liabilities
Current financial liabilities
Borrowings, current0.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises4.73
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises51.93
Total Trade payable56.66
Other current financial liabilities25.69
Total current financial liabilities82.35
Other current liabilities13.87
Provisions, current0.93
Current tax liabilities (Net)10.94
Deferred government grants, Current
Total current liabilities108.09
3Liabilities directly associated with assets in disposal group classified as held for sale
4Regulatory deferral account credit balances and related deferred tax liability
Total liabilities135.00
Total equity and liabilites651.44
Disclosure of notes on assets and liabilities

Cash flow statement indirect

Amount in (Crores)

ParticularsHalf Year ended (dd-mm-yyyy)
Date of start of reporting period01-04-2025
Date of end of reporting period30-09-2025
Whether results are audited or unauditedUnaudited
Nature of report standalone or consolidatedStandalone
Part IBlue color marked fields are non-mandatory.
1Statement of cash flows
Cash flows from used in operating activities
Profit before tax111.80
2Adjustments for reconcile profit (loss)
Adjustments for finance costs1.22
Adjustments for decrease (increase) in inventories0.00
Adjustments for decrease (increase) in trade receivables, current9.05
Adjustments for decrease (increase) in trade receivables, non-current1.70
Adjustments for decrease (increase) in other current assets5.82
Adjustments for decrease (increase) in other non-current assets0.00
Adjustments for other financial assets, non-current0.00
Adjustments for other financial assets, current0.00
Adjustments for other bank balances0.00
Adjustments for increase (decrease) in trade payables, current(12.94)
Adjustments for increase (decrease) in trade payables, non-current0.00
Adjustments for increase (decrease) in other current liabilities(1.37)
Adjustments for increase (decrease) in other non-current liabilities0.00
Adjustments for depreciation and amortisation expense18.65
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss0.00
Adjustments for provisions, current(2.87)
Adjustments for provisions, non-current0.00
Adjustments for other financial liabilities, current0.00
Adjustments for other financial liabilities, non-current0.00
Adjustments for unrealised foreign exchange losses gains0.00
Adjustments for dividend income0.00
Adjustments for interest income1.39
Adjustments for share-based payments11.56
Adjustments for fair value losses (gains)(3.94)
Adjustments for undistributed profits of associates0.00
Other adjustments for which cash effects are investing or financing cash flow0.00
Other adjustments to reconcile profit (loss)0.00
Other adjustments for non-cash items0.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships0.00
Total adjustments for reconcile profit (loss)25.49
Net cash flows from (used in) operations137.29
Dividends received0.00
Interest paid0.00
Interest received0.00
Income taxes paid (refund)18.50
Other inflows (outflows) of cash0.00
Net cash flows from (used in) operating activities118.79
3Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses0.00
Cash flows used in obtaining control of subsidiaries or other businesses0.00
Other cash receipts from sales of equity or debt instruments of other entities0.00
Other cash payments to acquire equity or debt instruments of other entities0.00
Other cash receipts from sales of interests in joint ventures0.00
Other cash payments to acquire interests in joint ventures1.06
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships0.00
Proceeds from sales of property, plant and equipment0.90
Purchase of property, plant and equipment10.26
Proceeds from sales of investment property0.00
Purchase of investment property0.00
Proceeds from sales of intangible assets0.00
Purchase of intangible assets0.00
Proceeds from sales of intangible assets under development0.00
Purchase of intangible assets under development0.00
Proceeds from sales of goodwill0.00
Purchase of goodwill0.00
Proceeds from biological assets other than bearer plants0.00
Purchase of biological assets other than bearer plants0.00
Proceeds from government grants0.00
Proceeds from sales of other long-term assets23.33
Purchase of other long-term assets2.46
Cash advances and loans made to other parties0.00
Cash receipts from repayment of advances and loans made to other parties0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts0.00
Dividends received0.00
Interest received1.39
Income taxes paid (refund)0.00
Other inflows (outflows) of cash0.00
Net cash flows from (used in) investing activities11.84
4Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries0.00
Payments from changes in ownership interests in subsidiaries0.00
Proceeds from issuing shares0.00
Proceeds from issuing other equity instruments0.00
Payments to acquire or redeem entity's shares0.00
Payments of other equity instruments0.00
Proceeds from exercise of stock options0.00
Proceeds from issuing debentures notes bonds etc0.00
Proceeds from borrowings0.00
Repayments of borrowings0.00
Payments of lease liabilities5.52
Dividends paid111.24
Interest paid0.00
Income taxes paid (refund)0.00
Other inflows (outflows) of cash0.00
Net cash flows from (used in) financing activities(116.76)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes13.87
5Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents0.00
Net increase (decrease) in cash and cash equivalents13.87
Cash and cash equivalents cash flow statement at beginning of period15.18
Cash and cash equivalents cash flow statement at end of period29.05

Audit qualification

Sr.Details of Audit QualificationType of Audit QualificationFrequency of qualificationFor Audit Qualification(s) where the impact is quantified by the auditorFor Audit Qualification(s) where the impact is not quantified by the auditor
Management's Views(i) Management's estimation on the impact of audit qualification(ii) If management is unable to estimate the impact, reasons for the sameAuditors Comments on (i) or (ii) above
No records available

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Amount in (Crores)

Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Sr. No.Details of the party (listed entity /subsidiary) entering into the transactionDetails of the counterpartyType of related party transactionDetails of other related party transactionValue of the related party transaction as approved by the audit committeeRemarks on approval by audit committeeValue of the related party transaction ratified by the audit committeeDate of Audit Committee Meeting where the ratification was approvedValue of transaction during the reporting periodIn case monies are due to either party as a result of the transactionIn case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investmentsDetails of the loans, inter-corporate deposits, advances or investments
NameNameRelationship of the counterparty with the listed entity or its subsidiaryOpening balanceClosing balanceNature of indebtedness (loan/ issuance of debt/ any other etc.)Details of other indebtednessCostTenureNature (loan/ advance/ intercorporate deposit/ investment)Interest Rate (%)TenureSecured/ unsecuredPurpose for which the funds will be utilised by the ultimate recipient of funds (endusage)Notes
1Thyrocare Technologies LimitedAarush Tirupati Enterprise (Unit of API)Ultimate Holding CompanyPurchase of goods or services10.00As Approved by the Audit committee0.0023-04-20250.050.000.00
2Thyrocare Technologies LimitedAkna Medical Private LimitedMember of same Group (API Holdings)Sale of goods or services0.10As Approved by the Audit committee0.0023-04-20250.900.090.00
3Thyrocare Technologies LimitedAscent Wellness & Pharma Solutions P LtdMember of same Group (API Holdings)Purchase of goods or services0.10As Approved by the Audit committee0.0023-04-20250.000.050.03
4Thyrocare Technologies LimitedAvighna Medicare Private LimitedMember of same Group (API Holdings)Sale of goods or services0.90As Approved by the Audit committee0.0023-04-20250.140.010.07
5Thyrocare Technologies LimitedAycon Graph Connect Pvt LtdMember of same Group (API Holdings)Sale of goods or services0.20As Approved by the Audit committee0.0023-04-20250.070.040.01
6Thyrocare Technologies LimitedAycon Graph Connect Pvt LtdMember of same Group (API Holdings)Any other transactionReimbursement of Expenses5.00As Approved by the Audit committee0.0023-04-20250.010.000.00
7Thyrocare Technologies LimitedAyro Retial Solutions Private LimitedMember of same Group (API Holdings)Sale of goods or services0.10As Approved by the Audit committee0.0923-04-20250.010.030.01
8Thyrocare Technologies LimitedDocon Technologies Private LimitedPromoterPurchase of goods or services10.00As Approved by the Audit committee0.0023-04-20252.040.000.00
9Thyrocare Technologies LimitedDocon Technologies Private LimitedPromoterAny other transactionReimbursement of Expenses25.00As Approved by the Audit committee0.0023-04-202510.180.000.00
10Thyrocare Technologies LimitedDocon Technologies Private LimitedPromoterSale of goods or services115.00As Approved by the Audit committee0.0023-04-202542.9428.7325.50
11Thyrocare Technologies LimitedDocon Technologies Private LimitedPromoterAny other transactionRental income2.00As Approved by the Audit committee0.0023-04-20250.040.000.00
12Thyrocare Technologies LimitedNueclear Healthcare LimitedSubsidary CompanyAny other transactionReimbursement of Expenses received2.50As Approved by the Audit committee0.0023-04-20250.680.000.00
13Thyrocare Technologies LimitedNueclear Healthcare LimitedSubsidary CompanyAny other transactionRental Income and Expenses4.00As Approved by the Audit committee0.0023-04-20250.510.000.00
14Thyrocare Technologies LimitedThink Health Diagnostics Private LimitedSubsidary CompanyAny other transactionReimbursement of Expenses- received5.00As Approved by the Audit committee0.0023-04-20250.000.000.00
15Thyrocare Technologies LimitedThink Health Diagnostics Private LimitedSubsidary CompanySale of goods or services5.00As Approved by the Audit committee0.0023-04-20250.010.080.07
16Thyrocare Technologies LimitedThrepsi Solutions Private LimitedMember of same Group (API Holdings)Any other transactionReimbursement of Expenses-received5.00As Approved by the Audit committee0.0023-04-20250.370.000.00
17Thyrocare Technologies LimitedThyrocare Laboratories (Tanzania) LimitedSubsidary CompanyAny other transactionReimbursement of Expenses-received2.00As Approved by the Audit committee0.0023-04-20250.120.000.00
18Thyrocare Technologies LimitedThyrocare Laboratories (Tanzania) LimitedSubsidary CompanySale of goods or services4.00As Approved by the Audit committee0.0023-04-20250.220.250.82
19Thyrocare Technologies LimitedPulse Hitech Health Services (Ghatkopar) LLPSubsidary CompanySale of goods or services5.00As Approved by the Audit committee0.0023-04-20250.690.160.24
20Thyrocare Technologies LimitedPulse Hitech Health Services (Ghatkopar) LLPSubsidary CompanyAny other transactionManagement Fees & Other service charges0.50As Approved by the Audit committee0.0023-04-20250.090.000.00
21Thyrocare Technologies LimitedAlok Kumar JagnaniKMPRemuneration0.00As approved by Nomination and Remuneration committee and Board0.0023-04-202551,57,024.000.000.00
22Thyrocare Technologies LimitedRahul GuhaKMPRemuneration0.00As approved by Nomination and Remuneration committee and Board0.0023-04-20252,88,70,998.000.000.00
23Thyrocare Technologies LimitedIndumati GopinathanIndependent DirectorAny other transactionSitting FeesAs approved by Nomination and Remuneration committee and Board0.0023-04-20253,00,000.000.000.00
24Thyrocare Technologies LimitedPrapti Ishwar GiladaIndependent DirectorAny other transactionSitting FeesAs approved by Nomination and Remuneration committee and Board0.0023-04-20255,00,000.000.000.00
25Thyrocare Technologies LimitedHarshil Jiten VoraIndependent DirectorAny other transactionSitting FeesAs approved by Nomination and Remuneration committee and Board0.0023-04-20251,50,000.000.000.00
26Thyrocare Technologies LimitedAnandh SundarIndependent DirectorAny other transactionSitting FeesAs approved by Nomination and Remuneration committee and Board0.0023-04-20252,50,000.000.000.00
27Thyrocare Technologies LimitedNishant ShahIndependent DirectorAny other transactionSitting FeesAs approved by Nomination and Remuneration committee and Board0.0023-04-20252,50,000.000.000.00
28Thyrocare Technologies LimitedVikram GuptaKMPRemunerationAs approved by Nomination and Remuneration committee and Board0.0023-04-202521,24,803.000.000.00
29Thyrocare Technologies LimitedBrijesh KumarKMPRemunerationAs approved by Nomination and Remuneration committee and Board0.0023-04-202520,97,937.000.000.00
Total value of transaction during the reporting period3,97,00,821.07
Objects for which funds have been raised and where there has been a deviation, in the following table:
Sr.Original ObjectModified Object, if anyOriginal AllocationModified allocation, if anyFunds UtilisedAmount of Deviation/Variation for the quarter according to applicable objectRemarks if any
No records available